Independent certification allows the company to produce for major retailers worldwide
HICKSVILLE, NY, Dec. 30, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in the development, production and sale of hemp-derived cannabinoid products, is pleased to to announce that its Pure Health product subsidiary has obtained GMP NSF/ANSI 455-2 dietary supplement certification from NSF International for its manufacturing facility in Lacey, Washington.
Marco Alfonsi, Managing Director of Can B, said: “This independent certification from the global public health organization demonstrates our commitment to quality personal care products and compliance with US GMP requirements. It verifies that our manufacturing plant has the appropriate methods, equipment, facilities and controls to produce dietary supplements. The importance of this price is that it now allows us to trade for any establishment on the planet.
Pure Health Products is a leader in formulating and manufacturing hemp-derived CBD products. The Pure Health team have been pioneers and innovators contributing to the evolution of the hemp industry. In our state-of-the-art facilities, we can create an existing line of private label products for any business, and/or our formulators can formulate custom products designed to appeal to a target market.
NSF/ANSI 455 GMP standards are designed to enhance safety, quality and confidence throughout the supply chain, combine regulatory requirements with retailer quality requirements and reduce audits and costs financial resources associated with audits. Using GMP guidelines helps companies develop and maintain appropriate controls in their manufacturing process so that products are processed, manufactured, and labeled consistently and meet quality standards.
“The NSF/ANSI 455 GMP mark indicates that an NSF International auditor has audited a facility, verified documents, and found the facility to be compliant with GMP regulations for production,” said David Trosin, Managing Director, Global Health Sciences Certification at NSF International. “We are very pleased to grant NSF/ANSI 455 GMP certification to this Pure Health Products manufacturing facility.”
NSF International is a global public health organization that facilitates new language standards and tests and certifies products for the water, food, health sciences and consumer goods industries to minimize adverse effects on health and protecting the environment. Founded in 1944, NSF is committed to protecting human health and safety worldwide. Present in more than 175 countries, NSF International is a Pan American Health Organization and World Health Organization (WHO) Collaborating Center on Food Safety, Water Quality, and the Indoor Environment.
For more information about NSF, please visit:
About Can B Corp.
Can B Corp. (OTCQB: CANB) is a health and wellness company that provides the highest quality hemp-derived cannabinoid products, including under its own brands Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. Can B uses multi-channel distribution to reach consumers, including medical institutions, doctor’s offices, retailers, online and face-to-face. Can B Corp. operates R&D and production facilities in Lacey, WA and Florida. To learn more about Can B Corp. and our full line of high quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook, or visit one of over 1,000 outlets that sell Can B Corp products.
For more information about Can B Corp., please visit: CanBCorp.com
Facebook @ Can B Corp
The forward-looking statements and risks and uncertainties discussed in this release contain forward-looking statements. The words “anticipate”, “believe”, “estimate”, “could”, “intend”, “expect” and similar expressions identify such forward-looking statements. Expected and actual results, performance or achievements may differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive and other factors affecting our operations, our markets, our products and our performance. . The matters discussed herein should in no way be construed in any way, form or manner as to our future financial condition or stock price. Except as required by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of latest information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unforeseen events.
Investors and media: